TickerFacts.

Burning Rock Biotech Ltd (BNR): Operating Cash Flow

Annual figures by period end, from SEC filings.

-28.44M CNY
Year ended 2025-12-31
2018-12-31: -148.78M CNY2019-12-31: -228.04M CNY2020-12-31: -73.54M CNY2021-12-31: -477.89M CNY2022-12-31: -456.81M CNY2023-12-31: -255.78M CNY2024-12-31: -92.26M CNY2025-12-31: -28.44M CNY-28.44M CNY
2018-12-31 Operating Cash Flow (CNY) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-28.44M CNYn/m2026-04-28, From 2025-01-01
2024-12-31-92.26M CNYn/m2026-04-28, From 2024-01-01
2023-12-31-255.78M CNYn/m2026-04-28, From 2023-01-01
2022-12-31-456.81M CNYn/m2025-04-29, From 2022-01-01
2021-12-31-477.89M CNYn/m2024-04-29, From 2021-01-01
2020-12-31-73.54M CNYn/m2023-04-20, From 2020-01-01
2019-12-31-228.04M CNYn/m2022-04-29, From 2019-01-01
2018-12-31-148.78M CNYn/a2021-03-23, From 2018-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Burning Rock Biotech Ltd (BNR)2025-12-31-28.44M CNYn/m
Concord Medical Services Holdings Ltd (CCM)2025-12-31-201.82M CNYn/m

Compare BNR, CCM side by side · Screen every company in Services-Medical Laboratories ↗